• Something wrong with this record ?

In vivo efficiency of antimicrobial inorganic bone grafts in osteomyelitis treatments

G. Mestres, MA. Fernandez-Yague, D. Pastorino, EB. Montufar, C. Canal, MC. Manzanares-Céspedes, MP. Ginebra,

. 2019 ; 97 (-) : 84-95. [pub] 20181128

Language English Country Netherlands

Document type Journal Article

The purpose of the present work was to evaluate in vivo different antimicrobial therapies to eradicate osteomyelitis created in the femoral head of New Zealand rabbits. Five phosphate-based cements were evaluated: calcium phosphate cements (CPC) and calcium phosphate foams (CPF), both in their pristine form and loaded with doxycycline hyclate, and an intrinsic antimicrobial magnesium phosphate cement (MPC; not loaded with an antibiotic). The cements were implanted in a bone previously infected with Staphylococcus aureus to discern the effects of the type of antibiotic administration (systemic vs. local), porosity (microporosity, i.e. <5 μm vs. macroporosity, i.e. >5 μm) and type of antimicrobial mechanism (release of antibiotic vs. intrinsic antimicrobial activity) on the improvement of the health state of the infected animals. A new method was developed, with a more comprehensive composite score that integrates 5 parameters of bone infection, 4 parameters of bone structural integrity and 4 parameters of bone regeneration. This method was used to evaluate the health state of the infected animals, both before and after osteomyelitis treatment. The results showed that the composite score allows to discern statistically significant differences between treatments that individual evaluations were not able to identify. Despite none of the therapies completely eradicated the infection, it was observed that macroporous materials (CPF and CPFd, the latter loaded with doxycycline hyclate) and intrinsic antimicrobial MPC allowed a better containment of the osteomyelitis. This study provides novel insights to understand the effect of different antimicrobial therapies in vivo, and a promising comprehensive methodology to evaluate the health state of the animals was developed. We expect that the implementation of such methodology could improve the criteria to select a proper antimicrobial therapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027876
003      
CZ-PrNML
005      
20190816111540.0
007      
ta
008      
190813s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.msec.2018.11.064 $2 doi
035    __
$a (PubMed)30678975
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Mestres, G $u Department of Engineering Sciences, Science for Life Laboratory, Uppsala University, Box 534, 751 21 Uppsala, Sweden.
245    10
$a In vivo efficiency of antimicrobial inorganic bone grafts in osteomyelitis treatments / $c G. Mestres, MA. Fernandez-Yague, D. Pastorino, EB. Montufar, C. Canal, MC. Manzanares-Céspedes, MP. Ginebra,
520    9_
$a The purpose of the present work was to evaluate in vivo different antimicrobial therapies to eradicate osteomyelitis created in the femoral head of New Zealand rabbits. Five phosphate-based cements were evaluated: calcium phosphate cements (CPC) and calcium phosphate foams (CPF), both in their pristine form and loaded with doxycycline hyclate, and an intrinsic antimicrobial magnesium phosphate cement (MPC; not loaded with an antibiotic). The cements were implanted in a bone previously infected with Staphylococcus aureus to discern the effects of the type of antibiotic administration (systemic vs. local), porosity (microporosity, i.e. <5 μm vs. macroporosity, i.e. >5 μm) and type of antimicrobial mechanism (release of antibiotic vs. intrinsic antimicrobial activity) on the improvement of the health state of the infected animals. A new method was developed, with a more comprehensive composite score that integrates 5 parameters of bone infection, 4 parameters of bone structural integrity and 4 parameters of bone regeneration. This method was used to evaluate the health state of the infected animals, both before and after osteomyelitis treatment. The results showed that the composite score allows to discern statistically significant differences between treatments that individual evaluations were not able to identify. Despite none of the therapies completely eradicated the infection, it was observed that macroporous materials (CPF and CPFd, the latter loaded with doxycycline hyclate) and intrinsic antimicrobial MPC allowed a better containment of the osteomyelitis. This study provides novel insights to understand the effect of different antimicrobial therapies in vivo, and a promising comprehensive methodology to evaluate the health state of the animals was developed. We expect that the implementation of such methodology could improve the criteria to select a proper antimicrobial therapy.
650    _2
$a zvířata $7 D000818
650    _2
$a antibakteriální látky $x aplikace a dávkování $x farmakokinetika $x farmakologie $7 D000900
650    _2
$a kostní cementy $x chemie $x farmakologie $7 D001843
650    _2
$a infekční nemoci kostí $x farmakoterapie $x terapie $7 D001850
650    _2
$a regenerace kostí $x účinky léků $7 D001861
650    _2
$a fosforečnany vápenaté $x chemie $7 D002130
650    _2
$a doxycyklin $x aplikace a dávkování $x farmakologie $7 D004318
650    _2
$a lékové transportní systémy $x metody $7 D016503
650    _2
$a implantované léky $x chemie $x farmakologie $7 D004343
650    _2
$a uvolňování léčiv $7 D065546
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a femur $x diagnostické zobrazování $x patologie $7 D005269
650    _2
$a osteomyelitida $x farmakoterapie $x terapie $7 D010019
650    _2
$a poréznost $7 D016062
650    _2
$a králíci $7 D011817
650    _2
$a stafylokokové infekce $x farmakoterapie $x terapie $7 D013203
650    _2
$a výsledek terapie $7 D016896
650    _2
$a viskoelastické látky $x chemie $7 D055682
655    _2
$a časopisecké články $7 D016428
700    1_
$a Fernandez-Yague, M A $u Biomaterials, Biomechanics and Tissue Engineering Group, Dpt. Materials Science and Metallurgy, Universitat Politècnica de Catalunya (UPC), Av. Eduard Maristany 10-14, 08019 Barcelona, Spain; Research Centre in Multiscale Science and Engineering, UPC, Barcelona, Spain.
700    1_
$a Pastorino, D $u Biomaterials, Biomechanics and Tissue Engineering Group, Dpt. Materials Science and Metallurgy, Universitat Politècnica de Catalunya (UPC), Av. Eduard Maristany 10-14, 08019 Barcelona, Spain; Research Centre in Multiscale Science and Engineering, UPC, Barcelona, Spain.
700    1_
$a Montufar, E B $u CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
700    1_
$a Canal, C $u Biomaterials, Biomechanics and Tissue Engineering Group, Dpt. Materials Science and Metallurgy, Universitat Politècnica de Catalunya (UPC), Av. Eduard Maristany 10-14, 08019 Barcelona, Spain; Research Centre in Multiscale Science and Engineering, UPC, Barcelona, Spain.
700    1_
$a Manzanares-Céspedes, M C $u Human Anatomy and Embryology Unit, University of Barcelona, Faculty of Medicine and Health Sciences, Barcelona, Spain; Growth factors and cellular differenciation (Bellvitge Biomedical Research Institute, IDIBELL) L'Hospitalet de Llobregat, Barcelona, Spain.
700    1_
$a Ginebra, M P $u Biomaterials, Biomechanics and Tissue Engineering Group, Dpt. Materials Science and Metallurgy, Universitat Politècnica de Catalunya (UPC), Av. Eduard Maristany 10-14, 08019 Barcelona, Spain; Research Centre in Multiscale Science and Engineering, UPC, Barcelona, Spain; Institute of Bioengineering of Catalonia (IBEC), Baldiri i Reixach 10-12, 08028 Barcelona, Spain. Electronic address: maria.pau.ginebra@upc.edu.
773    0_
$w MED00184559 $t Materials science & engineering. C, Materials for biological applications $x 1873-0191 $g Roč. 97, č. - (2019), s. 84-95
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30678975 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190816111810 $b ABA008
999    __
$a ok $b bmc $g 1433025 $s 1066336
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 97 $c - $d 84-95 $e 20181128 $i 1873-0191 $m Materials science & engineering. C, Materials for biological applications $n Mater Sci Eng C Mater Biol Appl $x MED00184559
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...